Xiaoling Du

1.8k total citations
53 papers, 1.3k citations indexed

About

Xiaoling Du is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Xiaoling Du has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 23 papers in Molecular Biology and 16 papers in Genetics. Recurrent topics in Xiaoling Du's work include Prostate Cancer Treatment and Research (16 papers), Estrogen and related hormone effects (12 papers) and Sarcoma Diagnosis and Treatment (8 papers). Xiaoling Du is often cited by papers focused on Prostate Cancer Treatment and Research (16 papers), Estrogen and related hormone effects (12 papers) and Sarcoma Diagnosis and Treatment (8 papers). Xiaoling Du collaborates with scholars based in China, United States and Austria. Xiaoling Du's co-authors include Jilong Yang, Jiandang Shi, Ju Zhang, Kexin Chen, Guowen Wang, Helmut Klocker, Yan Zhu, Wenxia Zhou, Jonathan C. Trent and Kelly K. Hunt and has published in prestigious journals such as Development, Cancer and International Journal of Molecular Sciences.

In The Last Decade

Xiaoling Du

51 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoling Du China 24 605 461 339 277 201 53 1.3k
Yan Gong China 16 421 0.7× 212 0.5× 212 0.6× 173 0.6× 187 0.9× 38 1.2k
Yong Xu China 26 1.1k 1.8× 404 0.9× 461 1.4× 631 2.3× 136 0.7× 83 2.1k
Penghong Song China 23 1.0k 1.7× 199 0.4× 301 0.9× 229 0.8× 70 0.3× 66 1.7k
Dongjun Jeong South Korea 21 798 1.3× 268 0.6× 528 1.6× 294 1.1× 154 0.8× 55 1.6k
Haiyan Yang China 23 604 1.0× 404 0.9× 498 1.5× 347 1.3× 35 0.2× 84 1.6k
Yao Yuan China 20 855 1.4× 185 0.4× 500 1.5× 376 1.4× 62 0.3× 72 1.6k
Jun Ho Yi South Korea 22 514 0.8× 214 0.5× 552 1.6× 324 1.2× 45 0.2× 88 1.5k
Piotr Potemski Poland 20 500 0.8× 143 0.3× 621 1.8× 266 1.0× 192 1.0× 119 1.4k
Wanfu Xu China 21 706 1.2× 242 0.5× 263 0.8× 386 1.4× 69 0.3× 60 1.3k
Weihua Jiang China 23 1.2k 1.9× 254 0.6× 351 1.0× 557 2.0× 83 0.4× 52 1.9k

Countries citing papers authored by Xiaoling Du

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Du more than expected).

Fields of papers citing papers by Xiaoling Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Du. The network helps show where Xiaoling Du may publish in the future.

Co-authorship network of co-authors of Xiaoling Du

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Du. A scholar is included among the top collaborators of Xiaoling Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Du. Xiaoling Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Qingye, et al.. (2025). ERK phosphorylates ESRRB to regulate the self-renewal and differentiation of mouse embryonic stem cells. Stem Cell Reports. 20(3). 102397–102397.
2.
Yu, Jiayu, Nannan Zhao, Yuying Wang, et al.. (2024). DCP1A, a MEK substrate, regulates the self-renewal and differentiation of mouse embryonic stem cells. Cell Reports. 43(12). 115058–115058.
3.
Zhang, Qingye, et al.. (2024). Glycolysis-Stimulated Esrrb Lactylation Promotes the Self-Renewal and Extraembryonic Endoderm Stem Cell Differentiation of Embryonic Stem Cells. International Journal of Molecular Sciences. 25(5). 2692–2692. 5 indexed citations
6.
Li, Peng, Xiaoling Du, Yiding Zhao, et al.. (2022). Homozygous Loss of Septin12, but not its Haploinsufficiency, Leads to Male Infertility and Fertilization Failure. Frontiers in Cell and Developmental Biology. 10. 850052–850052. 6 indexed citations
7.
Yang, Jilong, Chao Zhang, Fangyuan Chang, et al.. (2020). Aberrations of TBX2-CHK2-p53 Signaling Pathway and its Role in Malignant Peripheral Nerve Sheath Tumors. 1–10. 1 indexed citations
9.
Shi, Xiaoyu, Yanfei Peng, Xiaoling Du, et al.. (2017). Estradiol promotes epithelial‐to‐mesenchymal transition in human benign prostatic epithelial cells. The Prostate. 77(14). 1424–1437. 32 indexed citations
10.
Zhou, Wenya, Hong Zheng, Xiaoling Du, & Jilong Yang. (2016). Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patients. Cancer Biology and Medicine. 13(2). 260–268. 42 indexed citations
11.
Zhao, Gang, et al.. (2016). Clinical characteristics and prognostic indicators for metastatic melanoma: data from 446 patients in north China. Tumor Biology. 37(8). 10339–10348. 15 indexed citations
12.
Song, Fengju, Xiaoling Du, Guowen Wang, et al.. (2015). Advances in targeted therapy for unresectable melanoma: New drugs and combinations. Cancer Letters. 359(1). 1–8. 48 indexed citations
13.
Wang, Chao, Fei Luo, Ying Zhou, et al.. (2015). The therapeutic effects of docosahexaenoic acid on oestrogen/androgen-induced benign prostatic hyperplasia in rats. Experimental Cell Research. 345(2). 125–133. 15 indexed citations
14.
Yang, Jilong, et al.. (2014). The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.. Europe PMC (PubMed Central). 1. 18–18. 30 indexed citations
15.
Yang, Jilong, Matti Annala, Ping Ji, et al.. (2014). Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma. Journal of Hematology & Oncology. 7(1). 76–76. 28 indexed citations
16.
Du, Xiaoling, Rui Yang, Jie Liu, et al.. (2014). The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats. The Journal of Steroid Biochemistry and Molecular Biology. 145. 28–37. 32 indexed citations
17.
Yang, Jilong & Xiaoling Du. (2013). Genomic and molecular aberrations in malignant peripheral nerve sheath tumor and their roles in personalized target therapy. Surgical Oncology. 22(3). e53–e57. 9 indexed citations
18.
Peng, Yanfei, Jiandang Shi, Xiaoling Du, et al.. (2012). Prostaglandin E2 induces stromal cell-derived factor-1 expression in prostate stromal cells by activating protein kinase A and transcription factor Sp1. The International Journal of Biochemistry & Cell Biology. 45(3). 521–530. 16 indexed citations
19.
Duan, Lei, Xiaoling Du, Irwin Park, et al.. (2008). The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. The Prostate. 68(5). 508–516. 56 indexed citations
20.
Yang, Jilong, Xiaoling Du, Kexin Chen, et al.. (2008). Genetic aberrations in soft tissue leiomyosarcoma. Cancer Letters. 275(1). 1–8. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026